Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Better Pharmaceuticals Co., Ltd. (Better Pharma) is a pharmaceutical manufacturing company based in Shaoxing, Zhejiang, China, operating as a subsidiary of the publicly traded Zhejiang Sunflower Great Health Science & Technology Co., Ltd. Founded in 2004, the company specializes in the development, production, and commercialization of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and finished dosage forms. Its diverse product portfolio primarily targets therapeutic areas such as cardiovascular diseases, anti-infectives, and gastroenterology. Key commercialized products include clarithromycin, simvastatin, lacidipine, and various injectable formulations like esomeprazole sodium. Better Pharma operates large-scale manufacturing facilities built to international GMP standards, supplying products to both domestic and global healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江贝得药业.